• 2nd FDA approval for a Chinese pharmaceutical company
• 2nd FDA approval for a biosimilar developed by a Chinese Pharmaceutical company
API, Biological Drug Product, Formulation, mAb Formulation, mAbs
Bevacizumab
Related products
-
APIBivalirudin
CAS:128270-60-0Status:DMFIndications:Diseases of the circulatory system and diseases of the blood and hematopoietic organs -
-
APIDesmopressin
CAS:16679-58-6Status:DMF, CEP, KDMF, NMPA, WCIndications:Endocrine, nutritional, and metabolic diseases -
APIRetatrutide
CAS:2381089-83-2Status:R&DIndications:Endocrine, nutritional, and metabolic diseases